ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,331Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 623

$674K Total Retail Price of All Prescriptions

Rank: 18 out of 623

646 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 646 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 646 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 9,652 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 495 370 1 1
FUROSEMIDE 388 287 2 5
SIMVASTATIN 379 310 3 2
ATENOLOL 338 280 4 12
AMLODIPINE BESYLATE 331 265 5 3
METFORMIN HCL 302 251 6 6
LEVOTHYROXINE SODIUM 294 235 7 4
HYDROCHLOROTHIAZIDE 292 235 8 8
WARFARIN SODIUM 292 241 8 14
GABAPENTIN 276 221 10 18
TRAMADOL HCL 256 163 11 15
SERTRALINE HCL 254 143 12 20
METOPROLOL SUCCINATE 251 216 13 13
OMEPRAZOLE 245 206 14 7
HYDROCODONE-ACETAMINOPHEN 243 176 S3 15 17
METOPROLOL TARTRATE 232 190 16 9
CLOPIDOGREL 198 184 17 34
POTASSIUM CHLORIDE 187 168 18 24
ATORVASTATIN CALCIUM 160 143 19 10
PANTOPRAZOLE SODIUM 157 131 20 26
PLAVIX 149 137 21 46
CRESTOR 133 81 22 28
RANITIDINE HCL 125 99 23 23
DONEPEZIL HCL 118 118 24 27
CARVEDILOL 113 100 25 32
LOSARTAN POTASSIUM 111 88 26 16
NEXIUM 107 65 27 43
DIGOXIN 104 91 28 63
TAMSULOSIN HCL 104 82 28 35
AZITHROMYCIN 103 73 30 45
GLIPIZIDE 98 88 31 33
FOSINOPRIL SODIUM 90 90 32 186
ALLOPURINOL 90 88 32 44
LISINOPRIL-HYDROCHLOROTHIAZIDE 87 86 34 19
ZOLPIDEM TARTRATE 79 47 35 22
AMITRIPTYLINE HCL 79 47 R 35 135
NITROGLYCERIN PATCH 78 70 37 145
JANUVIA 76 59 38 87
DIOVAN 74 74 39 48
INSULIN SYRINGE 74 31 39 80
SPIRIVA 68 47 41 58
PREDNISONE 65 61 42 40
ADVAIR DISKUS 63 58 43 39
QUINAPRIL HCL 63 62 43 138
TRAZODONE HCL 60 34 45 36
CYCLOBENZAPRINE HCL 59 39 R 46 65
GLIMEPIRIDE 58 11 47 38
PRAVASTATIN SODIUM 57 47 48 11
AMOXICILLIN 56 39 49 98
DICLOFENAC SODIUM 55 31 50 213
CEPHALEXIN 55 34 50 102
NAPROXEN 55 42 50 89
CITALOPRAM HBR 54 37 53 21
ATENOLOL-CHLORTHALIDONE 54 54 53 152
LYRICA 53 41 55 86
CELEBREX 53 43 55 118
POLYETHYLENE GLYCOL 3350 52 43 57 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.